Literature DB >> 24798340

Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation.

Changcheng Zhao1, Devyn D Gillette1, Xinghui Li1, Zhibin Zhang1, Haitao Wen2.   

Abstract

Despite the number of extensive studies on the immune function and signaling of inflammasomes in various diseases, the activating mechanism of inflammasome, especially the NLRP3 inflammasome, is not fully understood. Nuclear factor E2-related Factor-2 (Nrf2), a key transcription factor that regulates cellular redox homeostasis, has been reported to play both protective and pathogenic roles depending on the disease conditions through undefined mechanism. This study reveals an essential role of Nrf2 in inflammasome activation. LPS stimulation increased Nrf2 protein levels in a Myd88-dependent manner. When compared with wild-type controls, Nrf2-deficient (Nrf2(-/-)) macrophages showed decreased maturation and secretion of caspase-1 and IL-1β and reduced apoptosis-associated speck-like protein containing CARD (ASC) speck formation in response to various NLRP3 and AIM2 inflammasome stimuli. In contrast, NLRC4 inflammasome activation was not controlled by Nrf2. Biochemical analysis revealed that Nrf2 appeared in the ASC-enriched cytosolic compartment after NLRP3 inflammasome activation. Furthermore, mitochondrial reactive oxygen species-induced NLRP3 activation also required Nrf2. Nrf2(-/-) mice showed a dramatic decrease in immune cell recruitment and IL-1β generation in alum-induced peritonitis, which is a typical IL-1 signaling-dependent inflammation animal model. This work discovered a critical proinflammatory effect of Nrf2 by mediating inflammasome activation.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24798340      PMCID: PMC4059144          DOI: 10.1074/jbc.M114.563114

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

2.  Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.

Authors:  Stefan Freigang; Franziska Ampenberger; Gunther Spohn; Sebastian Heer; Abdijapar T Shamshiev; Jan Kisielow; Martin Hersberger; Masayuki Yamamoto; Martin F Bachmann; Manfred Kopf
Journal:  Eur J Immunol       Date:  2011-06-08       Impact factor: 5.532

Review 3.  Regulation of inflammasome signaling.

Authors:  Vijay A K Rathinam; Sivapriya Kailasan Vanaja; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2012-03-19       Impact factor: 25.606

4.  Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis.

Authors:  Xiaoni Kong; Rajesh Thimmulappa; Florin Craciun; Christopher Harvey; Anju Singh; Ponvijay Kombairaju; Sekhar P Reddy; Daniel Remick; Shyam Biswal
Journal:  Am J Respir Crit Care Med       Date:  2011-07-28       Impact factor: 21.405

5.  Inflammasome is a central player in the induction of obesity and insulin resistance.

Authors:  Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 6.  The inflammasome NLRs in immunity, inflammation, and associated diseases.

Authors:  Beckley K Davis; Haitao Wen; Jenny P-Y Ting
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

7.  Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling.

Authors:  Haitao Wen; Denis Gris; Yu Lei; Sushmita Jha; Lu Zhang; Max Tze-Han Huang; Willie June Brickey; Jenny P-Y Ting
Journal:  Nat Immunol       Date:  2011-04-10       Impact factor: 25.606

8.  Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome.

Authors:  Franz Bauernfeind; Eva Bartok; Anna Rieger; Luigi Franchi; Gabriel Núñez; Veit Hornung
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

9.  Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice.

Authors:  Dionysios V Chartoumpekis; Panos G Ziros; Agathoklis I Psyrogiannis; Athanasios G Papavassiliou; Venetsana E Kyriazopoulou; Gerasimos P Sykiotis; Ioannis G Habeos
Journal:  Diabetes       Date:  2011-08-18       Impact factor: 9.461

10.  ER stress activates the NLRP3 inflammasome via an UPR-independent pathway.

Authors:  P Menu; A Mayor; R Zhou; A Tardivel; H Ichijo; K Mori; J Tschopp
Journal:  Cell Death Dis       Date:  2012-01-26       Impact factor: 8.469

View more
  58 in total

1.  MAVS-dependent host species range and pathogenicity of human hepatitis A virus.

Authors:  Asuka Hirai-Yuki; Lucinda Hensley; David R McGivern; Olga González-López; Anshuman Das; Hui Feng; Lu Sun; Justin E Wilson; Fengyu Hu; Zongdi Feng; William Lovell; Ichiro Misumi; Jenny P-Y Ting; Stephanie Montgomery; John Cullen; Jason K Whitmire; Stanley M Lemon
Journal:  Science       Date:  2016-09-15       Impact factor: 47.728

Review 2.  Nrf2 promotes survival following exposure to ionizing radiation.

Authors:  Konjeti R Sekhar; Michael L Freeman
Journal:  Free Radic Biol Med       Date:  2015-05-12       Impact factor: 7.376

3.  Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation.

Authors:  Mariela Castelblanco; Jérôme Lugrin; Driss Ehirchiou; Sonia Nasi; Isao Ishii; Alexander So; Fabio Martinon; Nathalie Busso
Journal:  J Biol Chem       Date:  2017-12-26       Impact factor: 5.157

4.  The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes.

Authors:  Nolan K Maier; Stephen H Leppla; Mahtab Moayeri
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

5.  The role of Nrf2 in NLRP3 inflammasome activation.

Authors:  Jhih-Jia Jhang; Gow-Chin Yen
Journal:  Cell Mol Immunol       Date:  2017-11-13       Impact factor: 11.530

Review 6.  NRF2 as a regulator of cell metabolism and inflammation in cancer.

Authors:  Feng He; Laura Antonucci; Michael Karin
Journal:  Carcinogenesis       Date:  2020-06-17       Impact factor: 4.944

Review 7.  Redox regulation of immunometabolism.

Authors:  Jonathan Muri; Manfred Kopf
Journal:  Nat Rev Immunol       Date:  2020-12-18       Impact factor: 53.106

8.  Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming.

Authors:  Xiuting Liu; Xin Zhang; Yang Ding; Wei Zhou; Lei Tao; Ping Lu; Yajing Wang; Rong Hu
Journal:  Antioxid Redox Signal       Date:  2016-08-09       Impact factor: 8.401

9.  Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.

Authors:  Xian Zhang; Jian-Hua Zhang; Xu-Yang Chen; Qing-Hua Hu; Ming-Xing Wang; Rui Jin; Qing-Yu Zhang; Wei Wang; Rong Wang; Lin-Lin Kang; Jin-Sheng Li; Meng Li; Ying Pan; Jun-Jian Huang; Ling-Dong Kong
Journal:  Antioxid Redox Signal       Date:  2015-04-01       Impact factor: 8.401

10.  Effects of Mammalian Thioredoxin Reductase Inhibitors.

Authors:  Elias S J Arnér
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.